1:00 PM – 1:15 PM

INTRODUCTIONS

1:15 PM – 2:30 PM

Mini Symposium on Follicular Lymphoma

• Molecular Genetics of FL
• Treatment of Newly Diagnosed Disease
• Treatment of Relapsed Disease and New Approvals

2:30 PM – 3:45 PM

Mini Symposium on CLL

• Frontline Treatment – Monotherapy, Double, or Triplet – What to Do?
• Biology of CLL at Progression: How Does That Inform Treatment
• Richter’s Transformation

3:45 PM – 4:00 PM

BREAK

4:00 PM – 5:30 PM

Considerations for Geriatric Lymphoma Patients

• Identification of Geriatric/Frail Patients in Lymphoma
• Goals for Treatment of Elderly HL Patients in the Era of Novel Combination Therapies
• Treating Elderly Patients with DLBCL

5:30 PM – 6:30 PM

WRAP UP/ RECEPTION & POSTER VIEWING

8:00 AM – 8:15 AM

INTRODUCTIONS

8:15 AM – 9:00 AM

Lymphoma Epidemiology: Findings from the Lymphoma SPORE Molecular Epidemiology Resource

9:00 AM – 10:00 AM

Chicago Hematopathology Multidisciplinary Tumor Board

• Hematopathologists and a Clinician Review 5 Case Vignettes and Discuss the Interplay in Diagnosis

10:00 AM – 10:15 AM

BREAK

10:15 AM – 10:45 AM

Hodgkin Lymphoma: How Best to Incorporate Targeted Therapeutics into 1L Hodgkin Lymphoma

10:45 AM – 11:30 AM

Keynote Presentation: Pathogenesis and Clinical Course of Aggressive Lymphomas

11:30 AM – 12:15 PM

LUNCH

12:15 PM – 1:30 PM

Mini Symposium on R/R DLBCL

• Cellular Therapy: Is the Efficacy of CAR T-cells Dependent Upon Lymphoma Subtype
• Immunotherapy Options for DLBCL Beyond CAR T-cells
• Non-Immunotherapy Options for R/R DLBCL

1:30 PM – 2:45 PM

Mini Symposium on T-Cell Lymphoma

• Systemic therapies for CTCL
• Newly Diagnosed PTCL
• R/R PTCL

2:45 PM – 3:00 PM

BREAK

3:00 PM – 4:00 PM

Mini Symposium on MCL

• When to Choose Intensive Induction Therapy
• Relapsed MCL: Treatment Options and Sequencing

4:00 PM – 4:15 PM

Best of IUCLS

4:15 PM – 4:30 PM

WRAP UP